Mikolaj Kocikowski
Overview
Explore the profile of Mikolaj Kocikowski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
30
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kocikowski M, Dziubek K, Wegrzyn K, Hrabal V, Zavadil-Kokas F, Vojtesek B, et al.
Front Immunol
. 2024 May;
15:1382576.
PMID: 38779661
Monoclonal antibodies targeting immune checkpoints have revolutionized oncology. Yet, the effectiveness of these treatments varies significantly among patients, and they are associated with unexpected adverse events, including hyperprogression. The murine...
2.
ONeill J, Mayordomo M, Mitulovic G, Al Shboul S, Bedran G, Faktor J, et al.
Mol Cell Proteomics
. 2024 Apr;
23(6):100764.
PMID: 38604503
Efforts to address the poor prognosis associated with esophageal adenocarcinoma (EAC) have been hampered by a lack of biomarkers to identify early disease and therapeutic targets. Despite extensive efforts to...
3.
Minoli L, Licenziato L, Kocikowski M, Cino M, Dziubek K, Iussich S, et al.
Cancers (Basel)
. 2022 Dec;
14(24).
PMID: 36551672
Canine apocrine gland anal sac adenocarcinoma (AGASACA) is an aggressive canine tumor originating from the anal sac glands. Surgical resection, with or without adjuvant chemotherapy, represents the standard of care...
4.
Bojko M, Wegrzyn K, Sikorska E, Kocikowski M, Parys M, Battin C, et al.
Bioorg Chem
. 2022 Aug;
128:106047.
PMID: 35963023
Over the past few years, many molecules such as monoclonal antibodies, affibodies, nanobodies, and small compounds have been designed and tested as inhibitors of PD-1/PD-L1 complex formation. Some of them...
5.
Uhrik L, Hernychova L, Muller P, Kalathiya U, Lisowska M, Kocikowski M, et al.
Biochem J
. 2020 Dec;
478(1):99-120.
PMID: 33284343
A comparative canine-human therapeutics model is being developed in B-cell lymphoma through the generation of a hybridoma cell that produces a murine monoclonal antibody specific for canine CD20. The hybridoma...
6.
Kocikowski M, Dziubek K, Parys M
Cancers (Basel)
. 2020 Apr;
12(4).
PMID: 32230745
Immune evasion is a major challenge for the development of successful cancer treatments. One of the known mechanisms is the expression of immune checkpoints (ICs)-proteins regulating the immune cells activation....
7.
Kote S, Faktor J, Dapic I, Mayordomo M, Kocikowski M, Kagansky A, et al.
Toxicon
. 2019 Jul;
169:1-4.
PMID: 31352010
Solitary aculeate wasps are abundant and diverse hymenopteran insects that disable prey using venom. The venom may possess neuromodulation, immunomodulatory, metabolic-modulatory and antimicrobial functions. Venom analysis of transcriptomes and proteomes...